Actively Recruiting
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Led by Jinling Hospital, China · Updated on 2022-12-20
236
Participants Needed
1
Research Sites
364 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.
CONDITIONS
Official Title
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with Crohn's disease needing bowel resection and anastomosis
- Ileocolic anastomosis
- Written consent acquired
You will not qualify if you...
- Patients who underwent enterostomy
- Small bowel anastomosis
- Anticipating participation in another trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China, 210002
Actively Recruiting
Research Team
M
ming duan, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here